project id: TCGA-HNSC; case submitter id: TCGA-QK-AA3J; source center: 23; state: released; a260 a280 ratio: 1.87; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.08; rna integrity number: 9.4; age at index: 69; days to birth: -25469; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1944; age at diagnosis: 25469; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage I; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T1; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 466.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8083/3; primary diagnosis: Basaloid squamous cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: No; is ffpe: false; composition: Not Reported; days to collection: 15; days to sample procurement: 0; initial weight: 10.0; portion submitter id: TCGA-QK-AA3J-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;